Improving Emergency Care and Outcomes of Immune-Related Adverse Events

Official Title Improving emergency care and outcomes of immune-related adverse events: The immune related emergency disposition index (irEDI)

Purpose

The purpose of this study is to learn more about how to best care for patients who have immune-related side effects and have received treatment with an immune checkpoint inhibitor. 

The duration of this study is 30 days. 

Could this study be right for you?

  • Must speak English and/or Spanish
  • Diagnosis of cancer (excluding non-melanoma skin cancer)
  • Last immunotherapy received within 90 days of study enrollment

Age Range

18 years and up